A number of research firms have changed their ratings and price targets for Bayer (FRA: BAYN):

  • 12/6/2018 – Bayer was given a new €72.00 ($83.72) price target on by analysts at Societe Generale. They now have a “neutral” rating on the stock.
  • 12/6/2018 – Bayer was given a new €84.00 ($97.67) price target on by analysts at Kepler Capital Markets. They now have a “buy” rating on the stock.
  • 12/5/2018 – Bayer was given a new €88.00 ($102.33) price target on by analysts at Sanford C. Bernstein. They now have a “buy” rating on the stock.
  • 12/4/2018 – Bayer had its “buy” rating reaffirmed by analysts at DZ Bank AG.
  • 12/3/2018 – Bayer was given a new €123.00 ($143.02) price target on by analysts at Baader Bank. They now have a “buy” rating on the stock.
  • 12/3/2018 – Bayer was given a new €77.00 ($89.53) price target on by analysts at Credit Suisse Group AG. They now have a “buy” rating on the stock.
  • 11/30/2018 – Bayer was given a new €69.00 ($80.23) price target on by analysts at Nord/LB. They now have a “neutral” rating on the stock.
  • 11/30/2018 – Bayer was given a new €69.00 ($80.23) price target on by analysts at Independent Research GmbH. They now have a “neutral” rating on the stock.
  • 11/30/2018 – Bayer was given a new €125.00 ($145.35) price target on by analysts at Deutsche Bank AG. They now have a “buy” rating on the stock.
  • 11/30/2018 – Bayer was given a new €84.00 ($97.67) price target on by analysts at Kepler Capital Markets. They now have a “buy” rating on the stock.
  • 11/30/2018 – Bayer was given a new €88.50 ($102.91) price target on by analysts at Warburg Research. They now have a “buy” rating on the stock.
  • 11/29/2018 – Bayer was given a new €88.00 ($102.33) price target on by analysts at Sanford C. Bernstein. They now have a “buy” rating on the stock.
  • 11/29/2018 – Bayer had its “buy” rating reaffirmed by analysts at JPMorgan Chase & Co..
  • 11/29/2018 – Bayer was given a new €78.00 ($90.70) price target on by analysts at Goldman Sachs Group Inc. They now have a “buy” rating on the stock.
  • 11/28/2018 – Bayer was given a new €90.00 ($104.65) price target on by analysts at Barclays PLC. They now have a “buy” rating on the stock.
  • 11/27/2018 – Bayer was given a new €99.00 ($115.12) price target on by analysts at Commerzbank AG. They now have a “buy” rating on the stock.
  • 11/27/2018 – Bayer was given a new €123.00 ($143.02) price target on by analysts at Baader Bank. They now have a “buy” rating on the stock.
  • 11/27/2018 – Bayer was given a new €96.00 ($111.63) price target on by analysts at equinet AG. They now have a “buy” rating on the stock.
  • 11/27/2018 – Bayer was given a new €77.00 ($89.53) price target on by analysts at Credit Suisse Group AG. They now have a “buy” rating on the stock.
  • 11/20/2018 – Bayer was given a new €78.00 ($90.70) price target on by analysts at Goldman Sachs Group Inc. They now have a “buy” rating on the stock.
  • 11/16/2018 – Bayer was given a new €105.00 ($122.09) price target on by analysts at Bank of America Corp. They now have a “buy” rating on the stock.
  • 11/14/2018 – Bayer was given a new €80.00 ($93.02) price target on by analysts at Cfra. They now have a “buy” rating on the stock.
  • 11/14/2018 – Bayer was given a new €77.00 ($89.53) price target on by analysts at Credit Suisse Group AG. They now have a “buy” rating on the stock.
  • 11/14/2018 – Bayer was given a new €99.00 ($115.12) price target on by analysts at Commerzbank AG. They now have a “buy” rating on the stock.
  • 11/14/2018 – Bayer was given a new €125.00 ($145.35) price target on by analysts at Deutsche Bank AG. They now have a “buy” rating on the stock.
  • 11/13/2018 – Bayer was given a new €72.00 ($83.72) price target on by analysts at Nord/LB. They now have a “neutral” rating on the stock.
  • 11/13/2018 – Bayer was given a new €70.00 ($81.40) price target on by analysts at Independent Research GmbH. They now have a “neutral” rating on the stock.
  • 11/13/2018 – Bayer was given a new €77.00 ($89.53) price target on by analysts at Jefferies Financial Group Inc. They now have a “neutral” rating on the stock.
  • 11/13/2018 – Bayer was given a new €88.50 ($102.91) price target on by analysts at Warburg Research. They now have a “buy” rating on the stock.
  • 11/13/2018 – Bayer was given a new €122.00 ($141.86) price target on by analysts at UBS Group AG. They now have a “buy” rating on the stock.
  • 11/13/2018 – Bayer was given a new €100.00 ($116.28) price target on by analysts at Barclays PLC. They now have a “buy” rating on the stock.
  • 11/13/2018 – Bayer was given a new €100.00 ($116.28) price target on by analysts at JPMorgan Chase & Co.. They now have a “buy” rating on the stock.
  • 11/13/2018 – Bayer was given a new €109.00 ($126.74) price target on by analysts at Goldman Sachs Group Inc. They now have a “buy” rating on the stock.
  • 11/13/2018 – Bayer was given a new €90.00 ($104.65) price target on by analysts at Sanford C. Bernstein. They now have a “buy” rating on the stock.
  • 11/12/2018 – Bayer was given a new €84.00 ($97.67) price target on by analysts at Kepler Capital Markets. They now have a “buy” rating on the stock.
  • 11/9/2018 – Bayer was given a new €123.00 ($143.02) price target on by analysts at Baader Bank. They now have a “buy” rating on the stock.
  • 11/8/2018 – Bayer was given a new €99.00 ($115.12) price target on by analysts at Commerzbank AG. They now have a “buy” rating on the stock.
  • 11/2/2018 – Bayer was given a new €111.00 ($129.07) price target on by analysts at Commerzbank AG. They now have a “buy” rating on the stock.
  • 11/2/2018 – Bayer was given a new €127.00 ($147.67) price target on by analysts at Deutsche Bank AG. They now have a “buy” rating on the stock.
  • 11/2/2018 – Bayer had its “buy” rating reaffirmed by analysts at JPMorgan Chase & Co.. They now have a price target on the stock.
  • 11/1/2018 – Bayer was given a new €90.00 ($104.65) price target on by analysts at Sanford C. Bernstein. They now have a “buy” rating on the stock.
  • 10/30/2018 – Bayer was given a new €109.00 ($126.74) price target on by analysts at Goldman Sachs Group Inc. They now have a “buy” rating on the stock.
  • 10/26/2018 – Bayer was given a new €95.00 ($110.47) price target on by analysts at Credit Suisse Group AG. They now have a “buy” rating on the stock.
  • 10/25/2018 – Bayer was given a new €127.00 ($147.67) price target on by analysts at Deutsche Bank AG. They now have a “buy” rating on the stock.
  • 10/24/2018 – Bayer was given a new €111.00 ($129.07) price target on by analysts at Commerzbank AG. They now have a “buy” rating on the stock.
  • 10/24/2018 – Bayer was given a new €123.00 ($143.02) price target on by analysts at Baader Bank. They now have a “buy” rating on the stock.
  • 10/23/2018 – Bayer was given a new €77.00 ($89.53) price target on by analysts at Jefferies Financial Group Inc. They now have a “neutral” rating on the stock.
  • 10/23/2018 – Bayer was given a new €122.00 ($141.86) price target on by analysts at UBS Group AG. They now have a “buy” rating on the stock.
  • 10/23/2018 – Bayer was given a new €96.00 ($111.63) price target on by analysts at equinet AG. They now have a “buy” rating on the stock.
  • 10/23/2018 – Bayer was given a new €111.00 ($129.07) price target on by analysts at Goldman Sachs Group Inc. They now have a “buy” rating on the stock.
  • 10/23/2018 – Bayer was given a new €89.00 ($103.49) price target on by analysts at Sanford C. Bernstein. They now have a “buy” rating on the stock.
  • 10/22/2018 – Bayer had its “buy” rating reaffirmed by analysts at JPMorgan Chase & Co..
  • 10/17/2018 – Bayer was given a new €111.00 ($129.07) price target on by analysts at Goldman Sachs Group Inc. They now have a “buy” rating on the stock.
  • 10/15/2018 – Bayer was given a new €89.00 ($103.49) price target on by analysts at Sanford C. Bernstein. They now have a “buy” rating on the stock.
  • 10/12/2018 – Bayer was given a new €127.00 ($147.67) price target on by analysts at Deutsche Bank AG. They now have a “buy” rating on the stock.
  • 10/11/2018 – Bayer was given a new €77.00 ($89.53) price target on by analysts at Jefferies Financial Group Inc. They now have a “neutral” rating on the stock.
  • 10/11/2018 – Bayer was given a new €84.00 ($97.67) price target on by analysts at Kepler Capital Markets. They now have a “buy” rating on the stock.
  • 10/11/2018 – Bayer was given a new €88.50 ($102.91) price target on by analysts at Warburg Research. They now have a “buy” rating on the stock.
  • 10/11/2018 – Bayer was given a new €96.00 ($111.63) price target on by analysts at equinet AG. They now have a “buy” rating on the stock.
  • 10/11/2018 – Bayer had its “buy” rating reaffirmed by analysts at JPMorgan Chase & Co..
  • 10/11/2018 – Bayer was given a new €123.00 ($143.02) price target on by analysts at Baader Bank. They now have a “buy” rating on the stock.
  • 10/11/2018 – Bayer was given a new €111.00 ($129.07) price target on by analysts at Commerzbank AG. They now have a “buy” rating on the stock.
  • 10/11/2018 – Bayer was given a new €111.00 ($129.07) price target on by analysts at Goldman Sachs Group Inc. They now have a “buy” rating on the stock.
  • 10/10/2018 – Bayer was given a new €122.00 ($141.86) price target on by analysts at UBS Group AG. They now have a “buy” rating on the stock.
  • 10/9/2018 – Bayer was given a new €100.00 ($116.28) price target on by analysts at Barclays PLC. They now have a “buy” rating on the stock.
  • 10/8/2018 – Bayer was given a new €89.00 ($103.49) price target on by analysts at Sanford C. Bernstein. They now have a “buy” rating on the stock.

BAYN stock opened at €63.97 ($74.38) on Thursday. Bayer AG has a 12-month low of €91.58 ($106.49) and a 12-month high of €123.82 ($143.98).

Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, Crop Science, and Animal Health segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents.

See Also: What is Cost of Debt?

Receive News & Ratings for Bayer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer AG and related companies with MarketBeat.com's FREE daily email newsletter.